healio.com
PHILADELPHIA — Sparsentan was shown to be safe and well-tolerated, and reduced proteinuria in adults with IgA nephropathy, according to studies presented at ASN Kidney Week.
In this video interview with Healio, Jula K. Inrig, MD, chief medical officer of Travere Therapeutics Inc., discussed findings from a preliminary trial that investigated the efficacy the novel, non-immunosuppressive,
about 1 year ago